ELRIG

Since incorporation in 2004, ELRIG has consolidated its reputation as a best in industry UK-based not-for-profit volunteer-led organisation, operated by and for the drug discovery community, and dedicated to the delivery of leading-edge scientific meetings and conferences on an open-access basis for optimum accessibility across all levels of its 22,000-strong global community.The Board delegates its tasks to a series of Work Groups, who work with the ELRIG team to ensure it achieves its objectives.ELRIG continuously strives to advance its ED&I and sustainability strategic pillars, to both inspire and align with the ESG strategies of its delegates, exhibitors, sponsors and all other stakeholders.For more information, visit the ELRIG website or follow on LinkedIn, X (formerly Twitter), Instagram and Bluesky.

Content by ELRIG

Drug Discovery USA 2026 logo
| 2 min read
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A 3D rendering illustrates a sandwich ELISA technique, where antigen detection is achieved between two layers of antibodies: a capture antibody and a detection antibody
Learn the key characteristics that determine whether an immunoassay generates accurate and reproducible data.
Illustration of translucent Y-shaped antibodies floating in a soft blue and green background, representing antibody research, development, and biomedical science.
Explore how antibody accessibility and custom development strategies can influence the pace and success of translational research.
Digital illustration of a glowing DNA double helix surrounded by interconnected circuit-like lines on a dark blue background.
Learn the key differences between chemical and enzymatic approaches to synthetic DNA production and their implications for modern research.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue